Stephen Gunstream

Stephen Gunstream, VP of BD Genomics


BD is a leading global medical technology company that services healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs more than 45,000 associates in 50 countries throughout the world. The company is dedicated to improving people’s health throughout the world.

Stephen Gunstream joined BD as Vice President Global Genomics in June 2015. In this role, Stephen leads our global Genomics efforts and advances our strategy for BD to become a leader in the area of Genomics sample preparation. Based out of California, Stephen leads a global BD Genomics team in partnership with all business units in the Life Sciences segment and the Genomics team at BD Technologies. He directly leads the BD GenCell Platform that we acquired in October 2014 and the Single Cell Genomics platform which includes the Cellular Research team we acquired in August 2015. As the global Genomics leader, Stephen is responsible for the business strategy and the overall Genomics P&L. Stephen is a member of the Life Sciences Segment Leadership Team and the BD Leadership Team.

Stephen joined BD from Integrated DNA Technologies where, until recently, he was the Chief Commercial Officer reporting to the CEO. He was accountable for both product development and global sales and marketing for the company. In his 7 years with IDT, he assumed several roles of increasing responsibility that contributed to a nearly three-fold revenue increase for IDT. Prior to IDT, he spent 7 years with Applied Biosystems (Thermo Fisher Scientific) in California.

Stephen has an undergraduate degree in Biomedical Engineering from Northwestern University, Evanston and an MBA from the Fuqua School of Business at Duke University. He is also named inventor on nine issued patents.

Listen to the interview with Stephen (published April 5, 2017):

New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup